Judge Allows Drug Battle Over TriCor To Proceed

Law360, New York (June 1, 2006, 12:00 AM EDT) -- In the latest in a long-running battle between pharmaceutical companies over generic versions of the cholesterol drug TriCor, a judge has ruled that a pending antitrust case against Abbott Laboratories can proceed.

Attorneys for Abbott Laboratories and Fournier Industrie et Sante asked Judge Kent Jordan to dismiss a lawsuit alleging that they manipulated antitrust laws to keep a generic equivalent of TriCor, or Fenofibrate, off the market.

Abbott markets TriCor in the U.S. for French drug maker Fournier.

Jordan dismissed the drug companies' arguments in a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.